Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Shares Issued (2024 - 2025)

Prelude Therapeutics' Shares Issued history spans 2 years, with the latest figure at $150000.0 for Q4 2025.

  • For Q4 2025, Shares Issued rose 20.97% year-over-year to $150000.0; the TTM value through Dec 2025 reached $433000.0, up 14.25%, while the annual FY2025 figure was $150000.0, 60.42% down from the prior year.
  • Shares Issued for Q4 2025 was $150000.0 at Prelude Therapeutics, up from -$92000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $251000.0 in Q3 2024 and bottomed at -$92000.0 in Q3 2025.